Memantine Sandoz

Memantine, the active ingredient in Memantine Sandoz, is a NMDA receptor antagonist presented as an oral tablet for oral use. It treats moderate to severe Alzheimer’s disease in adults.

GNH USA supplies Memantine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine is indicated for the treatment of Alzheimer’s disease, a neurodegenerative disorder affecting cognition and function.

Alzheimer's disease (moderate to severe): helps maintain cognitive performance and daily living abilities.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Fatigue - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., anaphylaxis, skin rash) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic injury - Cardiac arrhythmias - Suicidal thoughts or behavior

Safety considerations should be reviewed before initiating therapy. - Renal function: assess baseline and monitor periodically, especially in patients with renal impairment. - Seizure history: use with caution in individuals with a history of seizures. - Hepatic status: consider dose adjustment or close monitoring in hepatic disease. - Concomitant NMDA antagonists: avoid combined use to prevent additive neuro‑psychiatric effects. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potential drug‑drug interactions require clinical attention.

Major Interactions (Avoid): - Other NMDA receptor antagonists (e.g., amantadine, dextromethorphan): risk of additive neuro‑psychiatric effects. - Strong CYP450 inhibitors (e.g., ketoconazole, itraconazole): may increase memantine plasma levels.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effects. - Antihypertensive agents: monitor blood pressure for additive lowering. - CNS depressants (e.g., benzodiazepines, opioids): observe for increased sedation. - Drugs that lower seizure threshold (e.g., bupropion): watch for seizure risk. - Anticholinergic medications: may exacerbate confusion or cognitive changes.